DaVita Inc. (NYSE:DVA) Receives Consensus Recommendation of “Hold” from Analysts

DaVita Inc. (NYSE:DVA) has received a consensus rating of “Hold” from the six research firms that are currently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $166.33.

A number of equities analysts have commented on the stock. Sanford C. Bernstein set a $184.00 price target on shares of DaVita in a research report on Friday, February 21st. Barclays increased their price target on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 18th. StockNews.com upgraded DaVita from a “hold” rating to a “buy” rating in a research report on Thursday. Finally, Cowen restated a “hold” rating on shares of DaVita in a report on Tuesday, February 18th.

DaVita Trading Up 1.4 %

DVA stock opened at $155.48 on Wednesday. DaVita has a 1-year low of $125.64 and a 1-year high of $179.60. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18. The business’s 50 day moving average is $152.13 and its 200-day moving average is $156.59. The firm has a market cap of $12.44 billion, a P/E ratio of 14.48, a P/E/G ratio of 1.07 and a beta of 1.04.

DaVita (NYSE:DVA) last announced its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. Equities analysts anticipate that DaVita will post 10.76 earnings per share for the current fiscal year.

Hedge Funds Weigh In On DaVita

Large investors have recently made changes to their positions in the company. Copia Wealth Management acquired a new position in DaVita during the 4th quarter valued at about $30,000. SBI Securities Co. Ltd. acquired a new position in DaVita in the fourth quarter valued at approximately $41,000. Coppell Advisory Solutions LLC boosted its stake in DaVita by 50.0% in the fourth quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company’s stock valued at $45,000 after acquiring an additional 100 shares during the last quarter. Canada Post Corp Registered Pension Plan acquired a new stake in DaVita during the 4th quarter worth $55,000. Finally, Quarry LP acquired a new stake in DaVita during the 3rd quarter worth $60,000. Institutional investors and hedge funds own 90.12% of the company’s stock.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.